Capitalizing leadership acumen
for life science innovations

About Us


 

We advise, invest in and raise capital
for private and public life science companies

 

Areas of Focus

 
 
Disease Areas
mask group 29
NEUROLOGY
mask group 30
RARE DISEASE 
mask group 31
ONCOLOGY
mask group 32
CARDIOVASCULAR
Modalities
                   
 
mask group 36
GENE THERAPY
mask group 35
RNA
mask group 34
SMALL MOLECULES
mask group 33
BIOLOGICS
Modalities
For clients in the US and worldwide, we provide:
Allele Capital Partners believes in partnering with people who strongly value integrity and have a passion to make a meaningful impact in patients’ lives through life science innovations.

Testimonials


 

NEWS


View all news >
  • Dec 01, 2021

    BETHESDA, Md., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”), a...



  • Nov 16, 2021

    Plans to submit an IND to support a Phase 2b clinical trial for COYA101 HOUSTON, Nov. 16, 2021...



  • Nov 12, 2021

    Data from Patient-Derived iPSC Study Evaluating STAR Compounds Show Positive Effects on Disease Onset...